We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

AbCellera and Denali Therapeutics Sign Expanded Multi-Year, Multi-Target Deal to Discover Therapeutic Antibodies for Neurological Diseases

Product News   Mar 08, 2019

 
AbCellera and Denali Therapeutics Sign Expanded Multi-Year, Multi-Target Deal to Discover Therapeutic Antibodies for Neurological Diseases

Image credit: AbCellera

FURTHER INFORMATION
 
 
Advertisement
 

Related Product News

Optibrium Enhances Compound Design Strategies

Product News

Optibrium™ today announced the release of the newest version of StarDrop™, a comprehensive software platform for small molecule design, optimisation and data analysis.

READ MORE

Introducing a New Holographic Photostimulation Solution

Product News

Developed by Scientifica, the HoloStim-3D is a compact module that seamlessly integrates with the HyperScope multiphoton imaging system, providing a turnkey, fully integrated Spatial Light Modulator (SLM) based photostimulation solution.

READ MORE


Like what you just read? You can find similar content on the communities below.

Biopharma Cell Science Neuroscience Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE